Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry Study for Optimal Management of Liver Failure in the Chinese Population (RESOLVE-C)

NCT05740696 is registered in ClinicalTrials.gov with First Affiliated Hospital Xi'an Jiaotong University as lead sponsor.

NCT NCT05740696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05740696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry Study for Optimal Management of Liver Failure in the Chinese Population (RESOLVE-C)
Lead sponsor
First Affiliated Hospital Xi'an Jiaotong University
Phase
Observational
Overall status
Recruiting
Start date
January 6, 2023
Completion date
December 30, 2028
Enrollment
500 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

liver failure